Related Experiment Video
Updated: Sep 14, 2025
The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
Physical Performance and Patient-Reported Outcomes Remain Stable at 5 Years After Total Knee Arthroplasty
Pakpoom Ruangsomboon1,2, Onlak Ruangsomboon3,4, Chirathit Anusitviwat5
1Department of Orthopaedic Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Purpose:
To evaluate changes in physical performance tests (PPTs) and patient-reported outcome measures (PROMs) at baseline, 1 year after total knee arthroplasty (TKA), and a minimum of 5 years after TKA.
Methods:
We enrolled patients who underwent TKA between 2013 and 2015 performed by a single arthroplasty surgeon at Siriraj Hospital, Mahidol University, Bangkok, Thailand. We evaluated PPTs and PROMs over a minimum 5-year follow-up period to assess changes over time, identified independent factors associated with PPT deterioration, and determined TKA survivorship.
Results:
The study included 126 participants with a mean age of 77.8 years. The average follow-up time was 7.4 ± 2.3 years. PPTs and PROMs changed significantly over time from baseline. However, the 2-minute walk test and timed up-and-go test results slightly declined after 1 year but did not attain minimal clinically important differences, and PROMs were maintained and showed no clinically significant changes after 1 year. Hospitalizations owing to complex medical conditions or trauma were independently associated with PPT deterioration. There was a 98.8% survivorship rate at 7.6 years.
Conclusions:
In an Asian population undergoing TKA, PPTs and PROMs are maintained within acceptable ranges for at least 5 years after primary TKA. Trauma or hospitalizations arising from complex medical conditions were found to be associated with functional decline. A combined evaluation of PPTs and PROMs is advocated for a comprehensive assessment of patients after TKA.
Level Of Evidence:
Level III, cohort study.
